WeMed Medical Debuts Pioneering Hand-Eye-Brain Triad Collaborative Interventional Solution At WHX Miami 2026 in USA
WeMed Medical, a leading Chinese innovator in interventional healthcare technologies, officially introduced its "Hand-Eye-Brain" Collaborative Interventional Solution to the North American market at WHX Miami 2026, held from June 17 to 19 in the U.S. The debut highlights the company's continued commitment to advancing intelligent intervention through the seamless integration of imaging, robotics and AI.
WHX Miami 2026: Advancing Global Collaboration
WeMed Medical's presence at WHX Miami 2026 marks an important step in the company's global expansion strategy. By showcasing smarter, more efficient, and safer interventional solutions to international healthcare professionals, the company aims to further strengthen collaboration with global partners and clinical experts, while contributing to the continued advancement of interventional medical technology. Speaking about the strategic significance of the exhibition, Dashan Li, Overseas Marketing and Sales Director of WeMed Medical, noted at the event:
WHX Miami 2026 is far more than a traditional exhibition for showcasing innovative products. It serves as an important strategic platform for WeMed Medical to deepen its integration into the global healthcare ecosystem and accelerate local market development. Participating in this event marks a significant step forward in WeMed Medical's global journey.
As a major commercial hub connecting North America and the rapidly growing Latin American market, Miami holds unique strategic importance. We have brought not only our flagship products but also our "Hand-Eye-Brain" Collaborative Interventional Solution. Our objective extends beyond introducing innovative technologies to international markets. More importantly, we seek to engage in meaningful dialogue with clinical experts, distribution partners and stakeholders worldwide, working together to build a localized interventional ecosystem that addresses real clinical needs and delivers broad clinical value. We firmly believe that medical innovation achieves its greatest impact when it transcends borders, ultimately benefiting physicians and patients around the world.
From Precision Tools to Intelligent Intervention
The Endovascular Robotic System stands as the world's first fully self-developed coronary interventional robot featuring post-market force feedback capabilities, leading the global industry across multiple dimensions, including patent volume and cutting-edge technology deployment. By seamlessly integrating multimodal imaging, precision motion control, and intelligent AI analysis, the system delivers a robust, end-to-end intelligent surgical solution.
Complementing the robotics are the Medical Angiography X-ray System. Powered by an advanced intelligent supercomputing platform and equipped with ultra-high-definition imaging technologies, these systems enable smarter, faster image recognition and assistive diagnosis, providing ultra-clear, real-time vascular visualization during procedures.
Extending its clinical reach, WeMed Medical also showcased the Mobile C-arm X-ray System, a flagship, high-performance solution designed specifically for demanding orthopedic clinical applications. Featuring outstanding flexibility, agile maneuverability, and crystal-clear imaging, it provides physicians with high-precision imaging support in the operating room.
Shaping the Future of Interventional Care
As WeMed Medical expands its global presence, the launch of the "Hand-Eye-Brain" Triad Collaborative Interventional Solution represents a significant step forward in intelligent intervention. By integrating imaging, robotics, and AI into a unified platform, the solution enables a comprehensive data-driven workflow across the entire interventional process.
The introduction of this platform reflects the broader evolution of interventional medicine toward greater intelligence, automation, and clinical efficiency. It also demonstrates the growing contribution of Chinese medical technology innovation to the global healthcare landscape.
Looking ahead, WeMed Medical will continue to leverage artificial intelligence and robotics as key drivers of innovation, advancing interventional medicine from innovation pioneered in China to broader global adoption. Through ongoing technological development and international collaboration, the company remains committed to delivering smarter, safer, and more efficient solutions for physicians and patients worldwide.
